- Previous Close
0.0000 - Open
0.2400 - Bid 0.2628 x --
- Ask 0.3428 x --
- Day's Range
0.2400 - 0.2400 - 52 Week Range
0.2150 - 0.4657 - Volume
2,500 - Avg. Volume
572 - Market Cap (intraday)
47.351M - Beta (5Y Monthly) 1.39
- PE Ratio (TTM)
2.40 - EPS (TTM)
0.1000 - Earnings Date Feb 20, 2025
- Forward Dividend & Yield 0.01 (5.60%)
- Ex-Dividend Date Sep 3, 2024
- 1y Target Est
--
Integrated Research Limited designs, develops, implements, and sells systems and applications management computer software for business-critical computing, and unified communication and payment networks. The company offers Prognosis, an integrated suite of monitoring and management software designed to give an organization's management and technical personnel operational insight into the HP NonStop platform, distributed system servers, unified communications, payment environments, and the business applications. It also provides testing, maintenance, and professional services; and software as a service solution. The company offers its products in various countries through direct sales offices in the United States, the United Kingdom, Germany, Singapore, and Australia, as well as through channel-driven distribution networks internationally. It serves banks, credit card companies, telecommunications carriers, technology companies, service providers, and manufacturers. Integrated Research Limited was incorporated in 1988 and is based in Sydney, Australia.
www.ir.comRecent News: IREHF
View MorePerformance Overview: IREHF
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: IREHF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: IREHF
View MoreValuation Measures
Market Cap
53.48M
Enterprise Value
34.38M
Trailing P/E
2.45
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.80
Price/Book (mrq)
0.74
Enterprise Value/Revenue
0.66
Enterprise Value/EBITDA
2.16
Financial Highlights
Profitability and Income Statement
Profit Margin
28.79%
Return on Assets (ttm)
8.30%
Return on Equity (ttm)
25.18%
Revenue (ttm)
71.29M
Net Income Avi to Common (ttm)
20.52M
Diluted EPS (ttm)
0.1000
Balance Sheet and Cash Flow
Total Cash (mrq)
32.59M
Total Debt/Equity (mrq)
2.39%
Levered Free Cash Flow (ttm)
4.38M